257 related articles for article (PubMed ID: 9494600)
1. Pleural effusion as a significant prognostic factor in non-small cell lung cancer.
Naito T; Satoh H; Ishikawa H; Yamashita YT; Kamma H; Takahashi H; Ohtsuka M; Hasegawa S
Anticancer Res; 1997; 17(6D):4743-6. PubMed ID: 9494600
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
[TBL] [Abstract][Full Text] [Related]
3. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
Enatsu S; Yoshida J; Yokose T; Nishimura M; Nishiwaki Y; Shirakusa T; Nagai K
Ann Thorac Surg; 2006 Jan; 81(1):298-304. PubMed ID: 16368385
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer?
Vicidomini G; Santini M; Fiorello A; Parascandolo V; Calabrò B; Pastore V
Ann Thorac Surg; 2005 Jan; 79(1):254-7; discussion 254-7. PubMed ID: 15620952
[TBL] [Abstract][Full Text] [Related]
5. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW
Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636
[TBL] [Abstract][Full Text] [Related]
6. Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival?
Wang T; Nelson RA; Bogardus A; Grannis FW
Cancer; 2010 Mar; 116(6):1518-25. PubMed ID: 20108308
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution.
Maruyama R; Shoji F; Okamoto T; Miyamoto T; Miyake T; Nakamura T; Ikeda J; Asoh H; Yamaguchi M; Yoshino I; Ichinose Y
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1587-92. PubMed ID: 15173711
[TBL] [Abstract][Full Text] [Related]
8. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.
Shimizu K; Yoshida J; Nagai K; Nishimura M; Ishii G; Morishita Y; Nishiwaki Y
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):160-5. PubMed ID: 15999057
[TBL] [Abstract][Full Text] [Related]
9. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
10. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance and possibility in guiding adjuvant therapy of the pleural lavage cytology in patients with non-small cell lung cancer.
Nakamura T; Suzuki K; Mochizuki T; Ohde Y; Kobayashi H; Nakamura H; Toyoda F
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):321-4. PubMed ID: 19059950
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
Miyoshi K; Moriyama S; Kunitomo T; Nawa S
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
[TBL] [Abstract][Full Text] [Related]
14. [Study of prognostic factors in patients with stage I non-small cell lung cancer].
Jiang ZQ; Jiang GL; Shi DR; Zhang RX; Fu XL; Qian H
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):364-8. PubMed ID: 15312349
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of intraoperative pleural lavage cytology in non-small cell lung cancer.
Nakagawa T; Okumura N; Kokado Y; Miyoshi K; Matsuoka T; Kameyama K
Ann Thorac Surg; 2007 Jan; 83(1):204-8. PubMed ID: 17184663
[TBL] [Abstract][Full Text] [Related]
16. Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer.
van der Drift MA; Hol BE; Klaassen CH; Prinsen CF; van Aarssen YA; Donders R; van der Stappen JW; Dekhuijzen PN; van der Heijden HF; Thunnissen FB
Lung Cancer; 2010 May; 68(2):283-7. PubMed ID: 19632736
[TBL] [Abstract][Full Text] [Related]
17. Effects of prognostic factors and treatment on survival in advanced non-small cell lung cancer.
Cağlayan B; Fidan A; Salepçi B; Kiral N; Torun E; Salepçi T; Mayadağli A
Tuberk Toraks; 2004; 52(4):323-32. PubMed ID: 15558354
[TBL] [Abstract][Full Text] [Related]
18. Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination.
Kimura M; Tojo T; Naito H; Nagata Y; Kawai N; Taniguchi S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):568-71. PubMed ID: 20093263
[TBL] [Abstract][Full Text] [Related]
19. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
[TBL] [Abstract][Full Text] [Related]
20. Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology.
Satoh Y; Hoshi R; Ishikawa Y; Horai T; Okumura S; Nakagawa K
Ann Thorac Surg; 2007 Jan; 83(1):197-202. PubMed ID: 17184661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
